Researchers Identify Possible New HIV Therapy

IMAGE BY CGTOOLBOX/ISTOCK/GETTY IMAGES PLUS

Investigators in the Division of Infectious Diseases at the University of North Carolina (UNC) School of Medicine have found that macrophages, in addition to T cells, act as a reservoir for the human immunodeficiency virus (HIV). These findings could potentially shift the focus from clearing the virus from T cells to also eradicating it from macrophage-large white blood cells found throughout the body, including the liver, bone marrow, lung, and brain.

Published in Nature Medicine, the study, “HIV Persistence in Tissue Macrophages of Humanized Myeloid-Only Mice During Antiretroviral Therapy,” focused on how macrophages would respond to antiretroviral therapy (ART). Led by J. Victor Garcia, PhD, professor of medicine, microbiology and immunology at UNC School of Medicine, researchers used a mouse model lacking T cells to show that ART suppressed HIV replication in tissue macrophages. Viral rebound occurred in one third of the subject animals when HIV treatment was interrupted, according to the study.

“This is the first report demonstrating that tissue macrophages can be infected, and that they respond to antiretroviral therapy,” notes Jenna Honeycutt, PhD, the study’s lead author and postdoctoral research associate in the UNC Division of Infectious Diseases. “In addition, it shows that productively infected macrophages can persist despite ART — and, most importantly, that they can reinitiate and sustain infection upon therapy interruption, even in the absence of T cells — the major target of HIV infection.”

Add a Comment

Your email address will not be published. Required fields are marked *

The Viscardi Center And Henry Schein Announce ‘Project Accessible Oral Health’

New Coalition Aims to Shine Light on Significant Need to Enhance...

AAOMS honors oral and maxillofacial surgeons during Annual Meeting

SAN FRANCISCO, Calif. – More than 20 oral and maxillofacial surgeons...

Durable end to the HIV/AIDS pandemic likely will require an HIV vaccine

WHAT Despite remarkable gains in the treatment and prevention of HIV...

Outstanding Innovators In Dentistry Honored At 15th Annual Shils Awards Ceremony

The Dr. Edward B. Shils Entrepreneurial Fund Recognizes People, Organizations, and...

LANAP and LAPIP Protocols: Laser Gum Disease Protocols

Over 50% of US adults have gum disease.  Offer your patients...

IRIS HD USB 3.0 Intraoral Camera

Experience the Clarity in High Definition The new IRIS HD USB...

A New Adhesive/Primer Ideal for Indirect Restorations

At BISCO, adhesion is our passion. BISCO prides itself on developing...

KDZ Bruxer® Aesthetic

Bring the strength of full-contour zirconia into the facial zone with...